Physician profile
Bryce Carter
NPI 1992190326
$1,610.74
in general payments reported to CMS, 2019-2025
20 companies · $81.16 in 2025
The $81.16 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $107 · 2021: $172 · 2022: $245 · 2023: $283 · 2024: $570 · 2025: $81.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $401.43 | 2022-2024 | Qelbree |
| Corium, LLC | $218.91 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $187.70 | 2019-2024 | Jornay Pm |
| Tris Pharma INC | $171.92 | 2019-2022 | |
| Pfizer INC. | $105.29 | 2020-2025 | |
| Cranial Technologies, INC | $78.65 | 2019-2023 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $59.47 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $58.49 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $51.52 | 2019-2024 | Gardasil, Vaxelis, Vaxneuvance |
| Quidel Corporation | $40.80 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $38.68 | 2022-2023 | Crysvita |
| Sobi, INC | $34.65 | 2022-2023 | |
| Genzyme Corporation | $32.19 | 2023 | |
| Adlon Therapeutics L.P. | $28.16 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $20.00 | 2023 | Daybue |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $18.42 | 2023 | |
| Shire North American Group INC | $17.23 | 2019 | |
| Amphastar Pharmaceuticals, INC. | $16.94 | 2024 | Baqsimi |
| Collegium Pharmaceutical, INC. | $15.65 | 2025 | Jornay Pm |
| Dentsply Sirona INC | $14.64 | 2024 | Midwest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.